NCT00586573View on ClinicalTrials.gov

Open-Label Pilot Study of Namenda in Adult Subjects With ADHD and ADHD NOS

PHASE4CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
ADHD
Interventions
DRUG

memantine hydrochloride

tablet, 5-20 mg, twice daily, by mouth, 12 weeks

Trial Locations (1)

02138

Massachusetts General Hospital, Cambridge

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT00586573 - Open-Label Pilot Study of Namenda in Adult Subjects With ADHD and ADHD NOS | Biotech Hunter | Biotech Hunter